← Journal
MacroCautiousRegime · Iran ceasefire-deal negotiation deflates geopolitical risk premium; tech sector reclaims market leadership with QQQ +3.38% and XLK +3.73%; VIX declining from 22.22 to 19.44 toward neutral zone; deal remains unsigned with Tehran pushback; transitional regime from active-conflict defensive toward cautious-constructive with full cash buffer maintained until terms are formalized

Iran Deal Signal Unwinds Hormuz Hedge

Portfolio Exits XLE, Rotates Into Tech as Geopolitical Premium Deflates

Trump's claim that the Iran war is settled 'subject to finalization' drove a sharp de-escalation rally on June 12 — SPY +1.7%, QQQ +3.38%, VIX compressing to 19.44 — while XLE -1.94% confirmed the Hormuz risk premium is being priced out. The portfolio exits XLE as its founding thesis breaks, increases XLK to 15%, adds QQQ at 10%, and holds 50% cash pending deal finalization and Tehran's formal acceptance.

Published Jun 12, 2026Open Market Journal7 min readAI-assisted research · methodologyNot investment advice

Resulting portfolio change1 new • 1 add • 1 exit
  • Opened QQQ at 10%
  • Added to XLK from 10% to 15%
  • Exited XLE from 15%

What Happened Today

Friday, June 12 delivered one of the sharpest geopolitical repricing events of the year — in reverse. Rather than another escalation, markets received de-escalation: President Trump claimed the Iran conflict was "settled subject to finalization" and expected a formal signing "in the next few days." Oil prices fell immediately on the headline, XLE surrendered -1.94%, and the S&P 500 reversed the prior session's losses with a +1.7% gain while the Nasdaq surged +3.38%. The VIX compressed from 22.22 to 19.44 — not a fear-gauge collapse, but a clear signal that the market is no longer demanding the risk premium that was priced in across Tuesday and Wednesday.

Technology led. XLK +3.73%, QQQ +3.38%, NVDA +2.22%, AVGO +3.62%. The sector that absorbed the most punishment from the dual pressure of Iran risk-off and OpenAI pricing concerns staged its strongest single-day recovery since the May rebound. Small caps joined the bid with IWM +2.96%, and industrials (XLI +3.24%) confirmed that the rotation was broad rather than a narrow AI-only squeeze.

Energy was the day's clear underperformer. XLE -1.94%, XOM -2.67%. Oil prices fell on deal hopes — exactly the inverse of their behavior when strikes were first reported. The market is pricing the probability of a formal Iran agreement, and that probability is now high enough to unwind the premium that entered the crude complex when Kuwait closed airspace and Trump disclosed the Hormuz oil movements.

Gold added +3.13% to $386.32, but context is essential: bullion fell to a 6-month low earlier this week even as inflation fears rose, and today's bounce occurs from a deeply damaged technical position — $21.81 below SMA20 ($408.13) and $35.17 below SMA60 ($421.49). Gold's behavior reflects a fragmented safe-haven bid rather than a unified macro signal. TLT +1.3% above both moving averages suggests the long-duration bond market is taking the de-escalation seriously, pricing reduced tail risk without abandoning the rate-cut expectation entirely.

Portfolio Response: One Exit, One Increase, One New Position

The portfolio was built on a specific thesis that now faces a direct invalidating signal. Yesterday's XLE position was an explicit geopolitical hedge: "The 15% position converts Hormuz risk from a portfolio threat to a portfolio contributor." The invalidating condition for that thesis was always the same — evidence that Hormuz risk was being priced out. Today's news provided that evidence, and price action confirmed it. XLE -1.94% against a +1.7% SPY is not ambiguous.

The portfolio responds with three changes:

Exit XLE (15% → 0%). The founding thesis for this position was the repricing of Hormuz supply disruption risk following active U.S. strikes on Iran. That thesis required the geopolitical premium to remain elevated. Trump's "settled subject to finalization" claim, combined with reports that energy insiders in DC are actively discussing deal mechanics and oil prices falling sharply, signals the market is pricing out the disruption premium. XLE -1.94% today, below SMA20 ($58.37) and SMA60 ($58.28), with negative 20-day (-2.14%) and 60-day (-1.99%) momentum, confirms the hedge is no longer functioning as a hedge — it is a drag. Holding it past the thesis break crosses from discipline into stubbornness. Exited at today's session.

Increase XLK (10% → 15%). XLK +3.73% to $183.21 nearly recaptured its SMA20 ($183.77) — a level whose loss on June 11 was the trigger for the original trim from 15% to 10%. The 60-day momentum of +13.37% is the strongest directional signal in the candidate universe. The 20-day momentum recovery from -3.72% to -0.30% signals that the selling pressure tied to the OpenAI pricing headline is exhausting. As the Iran geopolitical premium deflates, the AI infrastructure capex narrative — the actual fundamental driver of the tech sector — reasserts itself. Weight increased from 10% to 15%.

Add QQQ at 10% (new position). The Nasdaq's +3.38% session gain reflects genuine risk-on rotation into the cohort with the clearest earnings leverage to AI capital expenditure cycles. QQQ at $717.12 is just 0.6% below SMA20 ($721.42); a formal deal signing would likely close that gap and confirm the technical recovery. The 60-day momentum of +8.23% is the strongest sustained reading among broad-index candidates. This is a structured expression of the de-escalation trade, sized conservatively at 10% because the deal is not yet signed.

Hold LLY at 15%. Eli Lilly +2.16% to $1,160.95. 20-day momentum +7.5%, 60-day +18.64%. The GLP-1 structural demand thesis has no mechanistic exposure to Iranian nuclear diplomacy, Hormuz logistics, or AI pricing competition. This position has delivered positive return in the risk-off session on June 11 and the risk-on session on June 12 — exactly the behavior of a position that belongs in the portfolio regardless of regime. Highest-conviction holding; unchanged.

Hold XLV at 10%. Healthcare +0.81% today — positive absolute return that also preserves the defensive function should the Iran deal collapse. 20-day momentum +3.12%, 60-day +4.74%, above both moving averages. The sector's diversification across pharma, managed care, and med-tech provides portfolio breadth without binary event risk. Held at 10% pending regime confirmation.

Cash held at 50%. The transition from "active conflict" to "deal in progress" is real but incomplete. Trump's qualifier — "subject to finalization" — is load-bearing. Tehran has publicly pushed back. The signing has not occurred. Reducing cash from 50% requires more than a presidential claim; it requires finalized terms. The 50% cash buffer preserves full optionality: deploy into tech and risk assets aggressively if the deal closes this weekend, or reinstate energy hedges and increase defensives if hostilities resume. Cash is not a default; it is the portfolio's highest-conviction macro call right now.

What Institutional Investors Are Signaling

Berkshire Hathaway's CVX position (6.6% of the portfolio as of the May 13F) is slow-moving context from a manager who holds energy through full cycles and is not a tactical trader. The CVX weight says nothing directional about this week's Iran headlines. Buffett's overall posture — concentrated in AAPL, AXP, KO, and BAC — reflects a preference for earnings durability and brand moat over geopolitical positioning.

Pershing Square's 17.4% AMZN and 15.3% MSFT are the institutionally relevant data points today. Ackman's willingness to hold two major AI-adjacent positions at combined 32.7% portfolio weight through the Iran escalation-and-deescalation cycle signals that his structural view on AI-driven revenue durability has not changed. That slow-moving institutional conviction reinforces the XLK increase and QQQ addition.

Bridgewater's index-first posture — SPY and IVV as the top two holdings at 12.7% and 10.7% respectively — reflects macro diversification rather than a single-thesis bet. Dalio's framework treats geopolitical events as transient disturbances to longer-duration macro cycles. The broad index positioning, combined with AMZN (4.1%) and NVDA (3.7%) as selective growth additions, is consistent with a portfolio that accepts geopolitical volatility without abandoning the AI-structural narrative.

Michael Burry's Scion filing (November 2025, stale context) showed 66% in PLTR and 13.5% in NVDA — a concentrated AI/data bet that has likely evolved since filing. The HAL energy position (oilfield services) at 4.5% is noted but not actionable given its staleness and single-company concentration.

What Could Break the Thesis

Iran deal collapse. Tehran's public pushback is the single largest risk to today's portfolio repositioning. If formal negotiations break down, hostilities resume, or the Hormuz transit corridor becomes contested again, the geopolitical risk premium would re-enter energy prices and re-exit tech multiples in a single session. The 50% cash position exists for this exact scenario — it funds an immediate XLE reinstatement and additional defensive repositioning without forced selling.

Tech multiple re-rating on Fed hawkishness. QQQ and XLK both carry negative 20-day momentum (-0.60% and -0.30% respectively), meaning the technical recovery is fragile rather than established. If CPI data due next week surprises to the upside or Fed speakers signal a higher-for-longer extension, duration-sensitive tech multiples would compress again. Both positions are sized at weights (15% and 10%) that allow further trimming without structural portfolio disruption.

Gold divergence as inflation signal. The CNBC headline Friday noted that gold is slumping to a 6-month low "even as inflation fears rise." This unusual divergence — typically gold rallies with inflation expectations — may reflect dollar strength from the Iran deal signal or institutional reallocation away from safe havens. If inflation proves stickier than priced and the gold-inflation correlation reasserts, the rate-path uncertainty that suppressed this market from April through May could return with full force.

Geopolitical contagion beyond Iran. The SpaceX IPO retail allocation cut and the ex-a16z commentary on AI political infiltration are background noise today. But the broader regulatory attention on tech scale and geopolitical alignment of AI infrastructure could compound into a sustained sentiment headwind if the macro backdrop deteriorates. This is a low-probability, high-impact tail risk rather than a base case.

The portfolio enters the weekend positioned to benefit from deal finalization while retaining the cash buffer to respond to scenario inversion. The Iran narrative is the single most important input for Monday's open.

Positioning

3 of 6 lines changed · weights sum to 100% · published Jun 12, 2026
  1. XLK15%was 10%Add 5 pts

    Increased from 10% to 15%. XLK +3.73% to $183.21, nearly recapturing its SMA20 ($183.77) — a near-complete technical recovery from the June 11 breakdown below that level that prompted the initial trim. The 60-day momentum of +13.37% is the strongest directional reading among all names in the candidate universe, and the 20-day momentum recovery from -3.72% to -0.30% signals that selling pressure tied to the OpenAI pricing headline and Iran risk-off bid is exhausting. As the Iran deal narrative deflates the geopolitical risk premium that had compressed AI-related capital expenditure sentiment, XLK's position as the clearest sector-level expression of that theme reasserts itself. Pershing Square's 15.3% MSFT allocation provides slow-moving institutional confirmation that concentrated investors are not abandoning AI-adjacent exposures through geopolitical volatility. Weight increased from 10% to 15% on SMA20 recapture attempt, momentum recovery, and de-escalation tailwind.

  2. QQQ10%was 0%New 10%

    New position at 10%. QQQ +3.38% to $717.12 — the strongest major-index print of the session, reflecting a risk-on rotation into the highest-beta AI-exposed cohort as the Iran deal narrative deflates geopolitical risk premium. Last price sits just 0.60% below SMA20 ($721.42); deal finalization in the coming days would likely provide the catalyst to close that gap and confirm the technical recovery. The 60-day momentum of +8.23% is the strongest sustained directional reading among broad-index candidates. Bridgewater's top two holdings — SPY and IVV — signal that large macro funds are maintaining broad index exposure rather than fleeing equities despite elevated uncertainty, while Pershing Square's 17.4% AMZN and 15.3% MSFT weights confirm that AI-adjacent concentration remains institutionally acceptable. New position initiated at 10% as a structured expression of the tech-led de-escalation rally, sized conservatively relative to the unsigned deal status.

  3. XLE0%was 15%Exit 15 pts

    No longer held in this published portfolio.

  4. LLY15%unchangedHold

    Held at 15%. Eli Lilly +2.16% to $1,160.95 — delivering positive absolute return for the second consecutive session regardless of regime, validating its role as the highest-conviction, geopolitically-orthogonal anchor. 20-day momentum of +7.5% and 60-day momentum of +18.64% represent the strongest sustained upward drift in the candidate universe. SMA20 cushion of $81.00 ($1,160.95 vs. SMA20 $1,079.95) and SMA60 cushion of $182.38 ($1,160.95 vs. SMA60 $978.57) reflect deep structural accumulation that has widened through both the risk-off selloff on June 11 and today's geopolitical de-escalation. The GLP-1 structural demand thesis has no mechanistic linkage to Iranian nuclear diplomacy, AI pricing competition, or rate-path uncertainty. This position performs its function in every scenario. Held at full weight.

  5. XLV10%unchangedHold

    Held at 10%. Healthcare Select Sector +0.81% — a positive absolute return in a risk-on session that also demonstrates the position's consistency across regimes: it outperformed SPY on the June 11 risk-off session and participates constructively on the June 12 risk-on session. 20-day momentum +3.12% and 60-day +4.74%, both positive, with last price of $154.09 well above SMA20 ($149.43) and SMA60 ($147.12). The sector's diversification across pharma, managed care, med-tech, and biotech provides portfolio breadth without the binary event exposure that concentrates risk in single-name tech or geopolitical hedges. The defensive anchor function is intact. Held at 10% pending clearer regime confirmation that the Iran deal is formalized.

  6. Cash50%unchangedHold

    Cash reserve at publication.

Sources and evidence

  1. Oil prices fall on hopes of U.S.-Iran deal despite Tehran pushback · CNBC
  2. Pirro's losses in Fed investigation should stay on the books, judge rules · CNBC
  3. Warren questions SpaceX IPO oversight in new letter to stock indexes · CNBC
  4. SpaceX cuts retail IPO allocation to low 20% range, source says · CNBC
  5. SpaceX to close above $2 trillion market cap on its debut, prediction market traders say · CNBC
  6. What energy insiders in DC are saying about oil prices and a possible Iran deal · CNBC
  7. Trump claims Iran war settled 'subject to finalization,' expects signing in 'next few days' · CNBC
  8. Ex-Andreessen Horowitz partner slams his old firm, other VCs for 'political infiltration' around AI · CNBC
  9. Healthy Returns: CVS Health executives on reducing healthcare's biggest pain points · CNBC
  10. Nearly 7 million student loan borrowers remain in defunct Biden-era payment plan: Trump official · CNBC
  11. Eaton moves one step closer to becoming a cleaner bet on the AI boom · CNBC
  12. Gold slumps to 6-month low even as inflation fears rise. Here's why bullion is out of favor · CNBC